CUI JINGRONG JEAN (Chief Scientific Officer) sold 1.7% of their position (12.21K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $581.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−5.98K
Price / share
$46.81
Trade value
$280.02K
% of position
Common Stock
Shares
−3.63K
Price / share
$47.82
Trade value
$173.40K
% of position
Common Stock
Shares
−1.89K
Price / share
$48.75
Trade value
$92.23K
% of position
Common Stock
Shares
−200.00
Price / share
$48.44
Trade value
$9.69K
% of position
Common Stock
Shares
−200.00
Price / share
$49.87
Trade value
$9.97K
% of position
Common Stock
Shares
−308.00
Price / share
$51.22
Trade value
$15.78K
% of position
Net shares
−12.21K
Net value
-$581.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/9/2020 | S · Sale | −5.98K | $46.81 | $280.02K | 0.8% | 726.59K | 720.61K |
| Common Stock Indirect | 4/9/2020 | S · Sale | −3.63K | $47.82 | $173.40K | 0.5% | 720.61K | 716.98K |
| Common Stock Indirect | 4/9/2020 | S · Sale | −1.89K | $48.75 | $92.23K | 0.3% | 716.98K | 715.09K |
| Common Stock Indirect | 4/13/2020 | S · Sale | −200.00 | $48.44 | $9.69K | 0.0% | 715.09K | 714.89K |
| Common Stock Indirect | 4/13/2020 | S · Sale | −200.00 | $49.87 | $9.97K | 0.0% | 714.89K | 714.69K |
| Common Stock Indirect | 4/13/2020 | S · Sale | −308.00 | $51.22 | $15.78K | 0.0% | 714.69K | 714.38K |
| Total | −12.21K | -$581.09K | ||||||
Common Stock
IndirectCommon Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Indirect |
| Common Stock | 1M | Direct |
| Total | 1.30M | 1M direct·300K indirect |